Select Locoregional therapies as a COVID-19 Risk Mitigation treatment strategy for HCC

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

Select Locoregional therapies as a COVID-19 Risk Mitigation treatment strategy for HCC

By Boston Scientific FEATURING Edward Kim, Riad Salem, Pavan Khanna, Juan Gimenez

172 views

September 2, 2020

Watch to hear Drs Riad Salem, Edward Kim, Pavan Khanna and Juan Gimenez speak about ...
read more ↘ recommendations and suggestions on how to manage the HCC in this COVID era.
↖ read less

Comments 0

Advancing the Science in Lung Cryoablation

Feat. M. Callstrom